Aquarius Surgical Technologies Inc.
AQQRF
$0.0042
$0.000.00%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 41.20K | 46.00K | 39.30K | 27.30K | 28.70K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 41.20K | 46.00K | 39.30K | 27.30K | 28.70K |
| Cost of Revenue | 19.10K | 5.30K | 17.50K | 16.70K | 23.60K |
| Gross Profit | 22.10K | 40.70K | 21.80K | 10.60K | 5.10K |
| SG&A Expenses | 90.60K | 140.70K | 96.10K | 122.10K | 150.10K |
| Depreciation & Amortization | 5.70K | 5.90K | 5.60K | 3.90K | 600.00 |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 115.40K | 151.90K | 119.20K | 142.70K | 174.30K |
| Operating Income | -74.20K | -105.90K | -79.90K | -115.40K | -145.60K |
| Income Before Tax | -135.80K | -124.90K | -137.00K | -76.40K | -190.30K |
| Income Tax Expenses | -- | 0.00 | 1.50K | -- | -- |
| Earnings from Continuing Operations | -135.80K | -124.90K | -138.40K | -76.40K | -190.30K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -135.80K | -124.90K | -138.40K | -76.40K | -190.30K |
| EBIT | -74.20K | -105.90K | -79.90K | -115.40K | -145.60K |
| EBITDA | -68.50K | -100.00K | -79.30K | -111.50K | -145.00K |
| EPS Basic | 0.00 | 0.00 | -0.01 | 0.00 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | -0.01 | 0.00 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 27.60M | 27.60M | 27.60M | 27.60M | 24.49M |
| Average Diluted Shares Outstanding | 27.60M | 27.60M | 27.60M | 27.60M | 24.49M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
